Oklo is trading at $30.20, down 4.97%, with nuclear-sector weakness and commercialization concerns weighing on shares.
- Shares fell 4.97% during the October 14 session.
- Recent coverage cited concerns about the time and capital needed to commercialize Oklo’s nuclear and isotope projects.
- Broader markets were lower, but major-index declines were more modest; no new company announcement explaining the intraday move was identified.